University of Oxford-led research finds low-dose rapamycin functions as a genomic protector in aging human immune cells, lowering DNA damage. The mechanistic target of rapamycin (mTOR) is a central ...

In the new study, scientists injected middle-aged mice with an antibody that blocks the action of interleukin-11, a protein that spurs inflammation and has been tied to aging processes in human cells.

Researchers have revealed that the human body's ageing process speeds up around age 50. It revealed that major changes happen between 45 and 55 years of age. The study also noted that different ...

Add Yahoo as a preferred source to see more of our stories on Google. “We would be able, by comparing and analyzing the data coming from these two different organoid, in the International Space ...

During the military parade celebrations in Beijing on September 3, 2025, China’s President Xi Jinping and Russia’s president Vladimir Putin were overheard talking about the prospects of organ ...

University of Oxford-led research finds low-dose rapamycin functions as a genomic protector in aging human immune cells, lowering DNA damage. Subscribe to our newsletter for the latest sci-tech news ...